Mr. Darnaud is a seasoned executive with 30 years of industry experience in medical technology, including two decades in international senior management positions.

Since 2008 he has been president of the Sorin Group’s Cardiopulmonary and Intercontinental business, with full global responsibility from R&D to sales. From 2005-2007, Mr. Darnaud was a consultant to executive search firm Spencer Stuart, where he established a presence for the firm in the medical technology sector in Europe. From 1998-2005, Mr. Darnaud was president of Boston Scientific’s European business, with full P/L responsibility across eight divisions, including interventional cardiology. Additionally, he was chairman of Eucomed (European Medical Device Industry Association) in 2004/2005.

Christophe Lottin, who has twenty years of experience in cardiology, rose through the sales organization of Boston Scientific and Hexacath France, up to the position of President with responsibility for Benelux, Switzerland and Canada. In particular, he was instrumental in the commercial success of the Optimax coronary stent. In his multiple roles, he had to coordinate the critical departments of a stent company, such as R&D, Clinical and Regulatory affairs.
Christophe was appointed CEO of STENTYS in summer 2016.

Marie Meynadier, Chief Executive Officer of EOS Imaging a pioneer in orthopaedic 2D/3D imaging, has been appointed by BPI-France to represent the institution on STENTYS Board of Directors. Mrs. Meynadier replaces Maïlys Ferrère.

After receiving her doctorate, Marie Meynadier joined Bellcore (Red Bank, NJ) and the prestigious ATT Bell Labs (Murray Hill, NJ), where she conducted research on semiconductor devices. Then, she returned to France to head up the management of major national and international development programs in electronics, optics and microelectronics, which enabled the creation of several start-ups in these areas. 

She joined the medical field in 1999, taking the lead at the start-up Biospace lab, which specialized in preclinical imaging. After rapidly turning the start-up into a profitable business, she founded EOS imaging.

Mrs. Sophie Baratte is Chief Executive Officer of medical technology company Cellnovo. She has spent the majority of her career in senior positions at major healthcare companies such as Johnson & Johnson, Sorin Group, CIT and Lifecell. She thus has extensive experience in sales and marketing, notably in bringing innovative technologies to market.

Professor Christian Spaulding is Professor of Cardiology at Paris Descartes University and Head of the Interventional Cardiology department at the Georges-Pompidou European Hospital, Paris. A member of the Cardiac Arrest Research Center at the PARCC Institute (Paris Cardiovascular Research Center), he has published more than 240 research articles in world-renown peer-reviewed scientific journals, notably on the issue of coronary stents and percutaneous coronary intervention techniques.